+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Device Validation & Verification Market - Global Forecast 2026-2032- Product Image
Medical Device Validation & Verification Market - Global Forecast 2026-2032- Product Image
Sale

Medical Device Validation & Verification Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5470778
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Medical Device Validation & Verification Market is projected to reach USD 1.41 Billion in 2026. It is expected to continue growing at a CAGR of 8.72%, reaching USD 2.34 Billion by 2032.

Medical device validation and verification (V&V) has become a board-level priority as manufacturers face tighter regulatory expectations, more software-driven products, and higher scrutiny of clinical performance, cybersecurity, usability, and postmarket risk controls. In this market, V&V is not a final-stage checklist; it is an evidence strategy that connects design inputs, risk management, biocompatibility, electrical safety, software lifecycle controls, human factors engineering, manufacturing validation, and real-world performance monitoring.

The strongest medical device companies are building V&V programs around globally recognized requirements, including ISO 13485 for quality management, ISO 14971 for risk management, IEC 62304 for medical device software, IEC 62366-1 for usability engineering, IEC 60601 for electrical safety, ISO 10993 for biological evaluation, and applicable FDA, EU MDR, IVDR, Health Canada, PMDA, NMPA, and TGA expectations. This shift is increasing demand for traceable test protocols, statistically justified sampling, digital validation platforms, and independent verification partners that can support faster, audit-ready submissions without compromising patient safety.

Transformative Shifts in the V&V Landscape

The medical device V&V landscape is being reshaped by three structural forces: regulatory convergence, software intensity, and lifecycle accountability. The U.S. FDA Quality Management System Regulation (QMSR), which aligns more closely with ISO 13485 and becomes effective in 2026, is reinforcing global expectations for risk-based quality systems. In parallel, EU MDR and IVDR have raised the evidence threshold for clinical evaluation, performance evaluation, postmarket surveillance, and technical documentation.

Manufacturers are also validating more connected, interoperable, and AI-enabled devices. This requires V&V teams to test beyond traditional mechanical and electrical performance, adding cybersecurity verification, cloud connectivity validation, data integrity checks, algorithm performance monitoring, and human-machine interaction assessments. As a result, leading organizations are moving from document-heavy validation to model-based design controls, automated test management, and continuous compliance frameworks that support regulatory submissions and ongoing device maintenance.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is changing medical device V&V by accelerating test design, anomaly detection, requirements traceability, and evidence review. AI-enabled tools can help identify gaps between user needs, design inputs, risk controls, test cases, and verification outputs, reducing manual reconciliation errors in complex product development programs. In software validation, machine learning can support automated regression testing, defect classification, and pattern recognition across large test datasets.

However, AI also increases validation complexity. AI-enabled medical device software must be evaluated for intended use, clinical relevance, dataset quality, bias, robustness, cybersecurity, and performance drift. Regulatory bodies increasingly expect transparent change control, documented training and test data governance, and lifecycle monitoring. The FDA’s framework for predetermined change control plans for AI-enabled device software functions, the IMDRF principles for software as a medical device, and emerging international work on AI risk management are pushing manufacturers toward continuous V&V models that combine premarket evidence with postmarket performance controls.

Key Regional Insights: Asia-Pacific, North America, Europe & Emerging Markets

Asia-Pacific is becoming a major V&V growth engine as China, Japan, South Korea, India, Australia, and ASEAN markets expand local manufacturing, digital health adoption, and regulatory modernization. China’s NMPA requirements, Japan’s PMDA review expectations, India’s medical device rule expansion, and Australia’s TGA frameworks are encouraging manufacturers to localize compliance evidence while maintaining global technical files. Across Asia-Pacific, demand is increasingly shaped by software-enabled devices, local type testing, clinical evidence requirements, and the need to align domestic submissions with internationally recognized standards.

North America remains a benchmark region because FDA and Health Canada expectations strongly influence global V&V planning, particularly for software, cybersecurity, quality systems, human factors, and clinical evidence. Europe continues to emphasize rigorous technical documentation under MDR and IVDR, creating sustained demand for gap assessments, clinical evaluation support, performance evaluation evidence, and notified body-ready validation packages. Latin America, led by Brazil and Mexico, is prioritizing regulatory harmonization and local registration efficiency, while the Middle East and Africa are building stronger medical device oversight as healthcare infrastructure investment expands and procurement systems place greater weight on certified quality, safety, and performance evidence.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7 & NATO

ASEAN markets are strengthening device oversight while promoting regional access, making harmonized V&V documentation valuable for manufacturers seeking multi-country approvals through aligned technical, safety, and performance evidence. GCC countries are aligning healthcare modernization with stricter procurement and regulatory expectations, increasing the need for safety, performance, cybersecurity, and quality evidence that supports hospital purchasing decisions and national health system modernization.

The European Union is the most influential group for MDR and IVDR compliance, requiring robust clinical, technical, postmarket surveillance, and vigilance documentation. BRICS economies are important for scale, local manufacturing, and cost-sensitive innovation, but they require careful navigation of country-specific testing, registration, labeling, and postmarket obligations. G7 countries continue to set expectations for advanced medical devices, cybersecurity, software assurance, and AI governance, while NATO-aligned procurement environments place additional emphasis on supply chain resilience, cybersecurity assurance, trusted quality systems, and continuity of supply for connected healthcare technologies.

Key Country Insights for Global Medical Device V&V Strategy

The United States is central to global V&V strategy due to FDA design controls, software guidance, cybersecurity expectations, human factors requirements, and the transition to QMSR. Canada emphasizes risk-based licensing and quality system evidence, while Mexico and Brazil are important Latin American access points with growing regulatory sophistication and increasing reliance on structured technical documentation. In Europe, the United Kingdom, Germany, France, Italy, and Spain remain critical markets where MDR-aligned evidence, clinical evaluation, usability, postmarket surveillance, and vigilance drive V&V priorities; Russia requires localized regulatory planning under separate national rules and distinct conformity assessment expectations.

China, India, Japan, Australia, and South Korea shape Asia-Pacific demand through a mix of rapid innovation and distinct regulatory pathways. China prioritizes NMPA evidence and local testing expectations, India is expanding medical device regulation and domestic manufacturing under a broader policy focus on quality and access, Japan applies PMDA rigor to safety, clinical performance, and manufacturing controls, Australia relies on TGA conformity assessment principles and recognized international evidence, and South Korea is known for advanced digital health adoption and regulatory focus on software-enabled devices. Together with the United States, Canada, Mexico, Brazil, the United Kingdom, Germany, France, Russia, Italy, Spain, Japan, Australia, and South Korea, these countries define the practical evidence requirements that manufacturers must address when designing globally scalable V&V strategies.

Actionable Recommendations for Industry Leaders

Industry leaders should adopt a risk-based V&V operating model that begins at user needs and continues through postmarket performance monitoring. The highest-impact move is to connect requirements management, hazard analysis, design verification, validation protocols, software testing, usability evidence, cybersecurity controls, supplier qualification, and production process validation in a single traceable system.

Companies should invest in automated test management, digital quality management systems, and standardized protocol libraries aligned with ISO 13485, ISO 14971, IEC 62304, IEC 62366-1, IEC 60601, ISO 10993, and applicable regional regulations. For AI-enabled and connected devices, leaders should establish data governance, model change control, penetration testing, secure update validation, bias assessment, and real-world performance monitoring before submission. Early engagement with regulators, notified bodies, and independent test laboratories can reduce rework, strengthen technical files, and improve approval readiness.

Research Methodology

This executive analysis is built on a structured secondary research methodology using publicly available regulatory, standards, and industry sources. Core references include FDA medical device quality and software guidance, EU MDR and IVDR requirements, IMDRF software principles, ISO and IEC standards relevant to device V&V, and national regulatory frameworks from authorities such as Health Canada, TGA, PMDA, NMPA, and other recognized agencies.

Insights were synthesized through regulatory mapping, standards alignment, regional policy review, technology trend analysis, and cross-comparison of device development requirements across major markets. The methodology prioritizes verifiable information, current regulatory direction, and practical implications for manufacturers, contract research organizations, testing laboratories, quality leaders, and regulatory affairs teams, while excluding market sizing, market share, and forecasting assumptions.

Conclusion

Medical device validation and verification is evolving into a continuous, data-driven discipline that determines market access, product reliability, and patient safety. The combination of stricter quality requirements, MDR and IVDR obligations, software-led innovation, cybersecurity risk, and AI-enabled functionality is raising expectations for evidence quality across the device lifecycle.

Organizations that treat V&V as an integrated strategic capability will be better positioned to shorten development cycles, withstand regulatory audits, and scale globally. Success will depend on traceability, risk-based testing, digital validation tools, regional regulatory intelligence, and continuous postmarket learning that keeps devices safe, effective, secure, and compliant.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Medical Device Validation & Verification Market, by Services
7.1. Introduction
7.2. Validation Services
7.2.1. Design Validation
7.2.2. Process Validation
7.2.3. Software Validation
7.3. Verification Services
7.3.1. Labeling & Packaging
7.3.2. Material Verification
7.3.3. Performance Testing
8. Medical Device Validation & Verification Market, by Device Class
8.1. Introduction
8.2. Class I
8.3. Class II
8.4. Class III
9. Medical Device Validation & Verification Market, by Device Type
9.1. Introduction
9.2. Imaging Systems
9.2.1. CT Scanners
9.2.2. MRI Systems
9.2.3. Ultrasound Systems
9.2.3.1. 2D Ultrasound
9.2.3.2. 3D/4D Ultrasound
9.2.4. X-Ray Systems
9.3. In Vitro Diagnostics
9.3.1. Blood Glucose Monitors
9.3.2. Immunoassay Analyzers
9.3.3. Molecular Diagnostics
9.4. Monitoring Devices
9.4.1. Blood Pressure Monitors
9.4.2. ECG Monitors
9.4.3. Fetal Monitors
9.4.4. Pulse Oximeters
9.5. Surgical Instruments
9.5.1. General Surgery Instruments
9.5.2. Laparoscopic Instruments
9.5.3. Orthopedic Instruments
9.6. Therapeutic Devices
9.6.1. Defibrillators
9.6.2. Dialysis Machines
9.6.3. Infusion Pumps
9.6.4. Ventilators
10. Medical Device Validation & Verification Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Neurology
10.4. Oncology
10.5. Orthopedics
10.6. Respiratory
11. Medical Device Validation & Verification Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.5. Hospitals
12. Medical Device Validation & Verification Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Medical Device Validation & Verification Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Medical Device Validation & Verification Market, by Country
14.1. Introduction
14.2. United States
14.3. China
14.4. Germany
14.5. United Kingdom
14.6. India
14.7. Japan
14.8. Russia
14.9. Brazil
14.10. Canada
14.11. Italy
14.12. Mexico
14.13. France
14.14. Spain
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. ALS Limited
16.2. Applus Services SA
16.3. ATIC (Guangzhou) Co., Ltd.
16.4. Bureau Veritas SA
16.5. Charles River Laboratories International, Inc.
16.6. CSA Group Testing & Certification Inc.
16.7. Dekra SE
16.8. DNV AS
16.9. Element Materials Technology Group Limited
16.10. Eurofins Scientific SE
16.11. IFS Aktiebolag
16.12. Intertek Group PLC
16.13. Kiwa NV
16.14. LabWare, Inc.
16.15. Medistri SA
16.16. NSF International
16.17. QuEST Global Services Pte. Ltd.
16.18. Riverside Company
16.19. SGS SA
16.20. Steris Laboratories
16.21. TUV Nord AG
16.22. TUV Rheinland Group
16.23. TÜV SÜD
16.24. UL LLC
17. Key Experts
List of Figures
FIGURE 1. Global Medical Device Validation & Verification Market, Years Considered for the Study
FIGURE 2. Global Medical Device Validation & Verification Market, Research Design
FIGURE 3. Global Medical Device Validation & Verification Market, Research Framework
FIGURE 4. Global Medical Device Validation & Verification Market, Data Triangulation
FIGURE 5. Global Medical Device Validation & Verification Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Medical Device Validation & Verification Market Size, by Services, 2025 vs 2032 (%)
FIGURE 7. Global Medical Device Validation & Verification Market Size, by Services, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Medical Device Validation & Verification Market Size, by Device Class, 2025 vs 2032 (%)
FIGURE 9. Global Medical Device Validation & Verification Market Size, by Device Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Medical Device Validation & Verification Market Size, by Device Type, 2025 vs 2032 (%)
FIGURE 11. Global Medical Device Validation & Verification Market Size, by Device Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Medical Device Validation & Verification Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Medical Device Validation & Verification Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Medical Device Validation & Verification Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Medical Device Validation & Verification Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Medical Device Validation & Verification Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Medical Device Validation & Verification Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Medical Device Validation & Verification Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Medical Device Validation & Verification Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Medical Device Validation & Verification Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Medical Device Validation & Verification Market Share, by Key Player, 2025
List of Tables
TABLE 1. Global Medical Device Validation & Verification Market Segmentation & Coverage
TABLE 2. Global Medical Device Validation & Verification Market Size, 2017-2032 (USD Million)
TABLE 3. Global Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 4. Global Validation Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Validation Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Validation Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Design Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Design Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Design Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Process Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Process Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Process Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Software Validation Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Software Validation Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Software Validation Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Verification Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Verification Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Verification Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Labeling & Packaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Labeling & Packaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Labeling & Packaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Material Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Material Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Material Verification Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Performance Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Performance Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Performance Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 29. Global Class I Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Class I Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Class I Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Class II Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Class II Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Class II Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Class III Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Class III Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Class III Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 39. Global Imaging Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Imaging Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Imaging Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global CT Scanners Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global CT Scanners Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global CT Scanners Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global MRI Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global MRI Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global MRI Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Ultrasound Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Ultrasound Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Ultrasound Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global 2D Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global 2D Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global 2D Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global 3D/4D Ultrasound Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global 3D/4D Ultrasound Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global 3D/4D Ultrasound Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global X-Ray Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global X-Ray Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global X-Ray Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global In Vitro Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global In Vitro Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global In Vitro Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Blood Glucose Monitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Blood Glucose Monitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Blood Glucose Monitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Immunoassay Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Immunoassay Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Immunoassay Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Monitoring Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Monitoring Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Monitoring Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Blood Pressure Monitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Blood Pressure Monitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Blood Pressure Monitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global ECG Monitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global ECG Monitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global ECG Monitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Fetal Monitors Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Fetal Monitors Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Fetal Monitors Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Pulse Oximeters Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Pulse Oximeters Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Pulse Oximeters Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Surgical Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Surgical Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Surgical Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global General Surgery Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global General Surgery Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global General Surgery Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Laparoscopic Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Laparoscopic Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Laparoscopic Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Orthopedic Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Orthopedic Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Orthopedic Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Therapeutic Devices Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Therapeutic Devices Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Therapeutic Devices Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Defibrillators Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Defibrillators Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Defibrillators Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Dialysis Machines Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Dialysis Machines Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Dialysis Machines Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Infusion Pumps Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Infusion Pumps Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Infusion Pumps Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Ventilators Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Ventilators Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Ventilators Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Orthopedics Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Orthopedics Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Orthopedics Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Respiratory Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Respiratory Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Respiratory Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 136. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 137. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 140. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 141. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 143. Global Medical Device Validation & Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Medical Device Validation & Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. North America Medical Device Validation & Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 159. North America Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 160. North America Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 161. North America Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 162. North America Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 163. North America Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 164. North America Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 165. North America Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 166. North America Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 167. North America Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 168. North America Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 169. North America Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 170. North America Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. North America Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Latin America Medical Device Validation & Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Latin America Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 174. Latin America Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 175. Latin America Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 176. Latin America Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 177. Latin America Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 178. Latin America Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 179. Latin America Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 180. Latin America Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 181. Latin America Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 182. Latin America Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 183. Latin America Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 184. Latin America Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Latin America Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. Europe Medical Device Validation & Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Europe Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 188. Europe Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 189. Europe Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 190. Europe Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 191. Europe Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 192. Europe Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 193. Europe Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 194. Europe Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 195. Europe Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 196. Europe Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 197. Europe Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 198. Europe Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Europe Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Middle East Medical Device Validation & Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 201. Middle East Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 202. Middle East Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 203. Middle East Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 204. Middle East Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 205. Middle East Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 206. Middle East Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 207. Middle East Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 208. Middle East Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 209. Middle East Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 210. Middle East Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 211. Middle East Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 212. Middle East Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. Middle East Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Africa Medical Device Validation & Verification Market Size, by Region, 2017-2032 (USD Million)
TABLE 215. Africa Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 216. Africa Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 217. Africa Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 218. Africa Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 219. Africa Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 220. Africa Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 221. Africa Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 222. Africa Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 223. Africa Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 224. Africa Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 225. Africa Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 226. Africa Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Africa Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. Global Medical Device Validation & Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. ASEAN Medical Device Validation & Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. ASEAN Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 231. ASEAN Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 232. ASEAN Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 233. ASEAN Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 234. ASEAN Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 235. ASEAN Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 236. ASEAN Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 237. ASEAN Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 238. ASEAN Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 239. ASEAN Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 240. ASEAN Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 241. ASEAN Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 242. ASEAN Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. GCC Medical Device Validation & Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 244. GCC Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 245. GCC Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 246. GCC Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 247. GCC Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 248. GCC Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 249. GCC Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 250. GCC Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 251. GCC Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 252. GCC Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 253. GCC Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 254. GCC Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 255. GCC Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. GCC Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. European Union Medical Device Validation & Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. European Union Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 259. European Union Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 260. European Union Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 261. European Union Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 262. European Union Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 263. European Union Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 264. European Union Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 265. European Union Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 266. European Union Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 267. European Union Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 268. European Union Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 269. European Union Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 270. European Union Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. BRICS Medical Device Validation & Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 272. BRICS Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 273. BRICS Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 274. BRICS Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 275. BRICS Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 276. BRICS Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 277. BRICS Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 278. BRICS Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 279. BRICS Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 280. BRICS Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 281. BRICS Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 282. BRICS Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 283. BRICS Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 284. BRICS Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 285. G7 Medical Device Validation & Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 286. G7 Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 287. G7 Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 288. G7 Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 289. G7 Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 290. G7 Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 291. G7 Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 292. G7 Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 293. G7 Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 294. G7 Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 295. G7 Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 296. G7 Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 297. G7 Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. G7 Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. NATO Medical Device Validation & Verification Market Size, by Group, 2017-2032 (USD Million)
TABLE 300. NATO Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 301. NATO Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 302. NATO Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 303. NATO Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 304. NATO Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 305. NATO Medical Device Validation & Verification Market Size, by Imaging Systems, 2017-2032 (USD Million)
TABLE 306. NATO Medical Device Validation & Verification Market Size, by Ultrasound Systems, 2017-2032 (USD Million)
TABLE 307. NATO Medical Device Validation & Verification Market Size, by In Vitro Diagnostics, 2017-2032 (USD Million)
TABLE 308. NATO Medical Device Validation & Verification Market Size, by Monitoring Devices, 2017-2032 (USD Million)
TABLE 309. NATO Medical Device Validation & Verification Market Size, by Surgical Instruments, 2017-2032 (USD Million)
TABLE 310. NATO Medical Device Validation & Verification Market Size, by Therapeutic Devices, 2017-2032 (USD Million)
TABLE 311. NATO Medical Device Validation & Verification Market Size, by Application, 2017-2032 (USD Million)
TABLE 312. NATO Medical Device Validation & Verification Market Size, by End User, 2017-2032 (USD Million)
TABLE 313. Global Medical Device Validation & Verification Market Size, by Country, 2017-2032 (USD Million)
TABLE 314. United States Medical Device Validation & Verification Market Size, 2017-2032 (USD Million)
TABLE 315. United States Medical Device Validation & Verification Market Size, by Services, 2017-2032 (USD Million)
TABLE 316. United States Medical Device Validation & Verification Market Size, by Validation Services, 2017-2032 (USD Million)
TABLE 317. United States Medical Device Validation & Verification Market Size, by Verification Services, 2017-2032 (USD Million)
TABLE 318. United States Medical Device Validation & Verification Market Size, by Device Class, 2017-2032 (USD Million)
TABLE 319. United States Medical Device Validation & Verification Market Size, by Device Type, 2017-2032 (USD Million)
TABLE 320. United States Medical Device Validation & Verification

Companies Mentioned

  • ALS Limited
  • Applus Services SA
  • ATIC (Guangzhou) Co., Ltd.
  • Bureau Veritas SA
  • Charles River Laboratories International, Inc.
  • CSA Group Testing & Certification Inc.
  • Dekra SE
  • DNV AS
  • Element Materials Technology Group Limited
  • Eurofins Scientific SE
  • IFS Aktiebolag
  • Intertek Group PLC
  • Kiwa NV
  • LabWare, Inc.
  • Medistri SA
  • NSF International
  • QuEST Global Services Pte. Ltd.
  • Riverside Company
  • SGS SA
  • Steris Laboratories
  • TUV Nord AG
  • TUV Rheinland Group
  • TÜV SÜD
  • UL LLC

Table Information

Report AttributeDetails
No. of Pages195
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.41 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.34 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned24

Related Topics

Related Reports

Medical Device Validation and Verification - Global Strategic Business Report - Product Image

Medical Device Validation and Verification - Global Strategic Business Report

  • Report
  • 378 Pages
  • Global
From
Preclinical Medical Device Testing Services Market - Global Forecast 2026-2032 - Product Image

Preclinical Medical Device Testing Services Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Medical Device Testing Market - Global Forecast 2026-2032 - Product Image

Medical Device Testing Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Surgical and Medical Instrument (Medical Devices) Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA - Product Image

Surgical and Medical Instrument (Medical Devices) Manufacturing (U.S.) Financial Analysis, Market Size & Benchmarks, and Revenue Forecasts to 2032 with P&L, KPIs, and EBITDA

  • Report
  • 108 Pages
  • United States
From
Sphygmomanometer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Sphygmomanometer - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.